Efficacy and Tolerability of Novel A2A Agonist in Treatment of Diabetic Neuropathic Pain
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and tolerability of BVT.115959 in
diabetic patients with neuropathic pain who are either not on analgesia or are on stable
analgesia in the month prior to entering the study.